Danish drugmaker Lundbeck has announced to acquire US company Longboard Pharmaceuticals in a deal valued at approximately $2.6 billion. Longboard, headquartered in La...
21.03.2018
- Danish drugmaker Lundbeck has announced plans to buy Swiss drug developer Prexton Therapeutics in a deal worth up to €905 million. The deal would give Lundbeck global rights to...
24.01.2014
- The Illinois Biotechnology Industry Organization (iBIO) today announced the election of Andy Hull as chairman of the iBIO Board of Directors, and the election of Linda Friedman, as...
15.08.2013
- China is intensifying its investigation into rampant bribery in the pharmaceutical and medical services sector with a fresh three-month probe slated to begin on Thursday, the...
08.08.2013
- Danish pharmaceuticals group Lundbeck posted a bigger-than-expected operating loss in the second quarter, hit by an EU fine for breaking competition law and cheap competition after...
20.06.2013
- European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant to...
03.06.2013
- A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said...
